Bulgaria: medical and donor requirements for assisted reproduction
Governing law and the clinical distinction
Bulgarian assisted reproduction law permits regulated use of donated sperm and eggs in specified treatment pathways. That is not authorization for a surrogacy programme. Annex 1, section I, item 5.7.9 of Ordinance No. Н-2/2023 prohibits achieving surrogate pregnancies in the section governing donor gametes. A proposed donor-egg IVF cycle in which the recipient herself carries the pregnancy therefore raises a different legal question from transferring an embryo to someone engaged to carry for others. Decide who will gestate before discussing donors or costs.
The governing framework includes Health Act articles 129–133 and Ordinance No. Н-2 of 12 July 2023, published in State Gazette No. 63 of 25 July 2023. The ordinance establishes the binding assisted-reproduction medical standard in Annex 1 and regulates collection, screening, traceability and storage of gametes. The original State Gazette text was checked, but the exact consolidated wording and any later amendments must be confirmed before treatment. Clinic websites and treatment quotations are not substitutes for legislation.
Three separate approvals are often confused: a patient may be medically suitable for an IVF procedure; donated gametes may have passed mandatory screening; and the intended arrangement must independently be lawful. Satisfying the first two cannot repair a prohibited gestational arrangement. Likewise, a laboratory's ability to freeze or import cells does not itself prove permission to transfer them to a gestational carrier. The identities of the egg provider, sperm provider, actual recipient and person who will carry the pregnancy are decisive facts.
The prohibition has an important drafting nuance. Item 5.7.9 appears under the clause 'when using donor gametes, the following are not permitted'. It supports a direct prohibition on surrogate pregnancies in that setting; this single subsection alone should not be stretched into an exhaustive opinion on every conceivable own-gamete arrangement. Equally, silence regarding a hypothetical arrangement is not affirmative permission. Obtain an independent Bulgarian legal determination before any embryo transfer intended for a third-party carrier, whether compensated or unpaid.
Egg recipients and donors
For ordinary treatment using the recipient's own eggs, article 11 requires an indication for treatment, absence of contraindications, checks for prohibited close kinship with the sperm provider, microbiology and infectious-disease investigations and written informed consent. Article 11 also addresses infection-positive patients with tailored treatment and storage rules. A clinic cannot replace mandatory consent or medical exclusions with a private waiver. A donor application and a patient receiving treatment need different evidence, even if the same doctor coordinates both.
Egg donation to another woman may be anonymous or from specified relatives, such as a sister or female cousin, under articles 12–13; documentary proof of kinship is retained. The donor must be older than 18 and legally capable. The evaluating doctor assesses fertility and age; donation up to age 38 is recommended rather than an absolute statutory maximum. When the donor is 38 or older, article 13 requires PGT-A of resulting embryos. Do not describe the 38-year recommendation as a blanket legal age ban.
Article 13 additionally requires a notarised donor consent, a physical and mental health assessment documented by a commission of at least three doctors independent of the retrieval team, and generally at least one live-born child. The live-child requirement has an express exception where the oocytes were obtained in another EU member state that has no equivalent rule. Imported eggs therefore need a documented origin and legal assessment, not an assumption that every local donor criterion disappears. For egg retrieval in Bulgaria, article 13(1)(3) specifies a notary whose territorial district includes the facility performing the retrieval; ask the facility to confirm how this formal requirement will be met.
Before egg retrieval, the ordinance requires a vaginal and cervical microbiological examination within 30 days and negative specified blood tests for HIV, hepatitis B, hepatitis C and syphilis within three months. Further testing can depend on travel and other risk factors; donor medical and family history also matters. Positive screening findings are not an invitation to relabel a donor as a 'known carrier' and proceed: the mandatory donor exclusions and treatment-specific rules must be applied separately.
Sperm donor rules and infections
Partner sperm and sperm from an unrelated donor follow distinct procedures. Articles 4–6 address partner collection, consent, kinship declarations, microbiology and, for indirect use, infectious screening. Articles 7–9 cover non-partner donors: health and family-genetic history, register checks, suitable laboratory results, written consent and protection of donor identity. A donor who is safe for one use is not automatically approved for every type of assisted reproduction.
Under article 8 non-partner donor sperm is generally processed and quarantined for at least 180 days, followed by confirmation of negative transmissible-disease tests. The same article provides specified exceptions to repeat testing, including properly performed NAT testing at donation or validated viral inactivation; they are not a general waiver of screening or traceability. Ask the clinic for the quarantine and test-release basis of the particular batch rather than treating a sperm-bank marketing description as evidence. Annex 1 item 5.6 separately refers to NAT testing when donor sperm has not undergone the 180-day quarantine, while article 8(2) expressly requires quarantine. The relationship between these provisions cannot safely be treated as a blanket permission to replace quarantine with NAT; require a written batch-specific explanation and current Bulgarian legal verification.
Infections require careful category-by-category analysis. Annex 1 item 5.7 excludes donation from donors positive for HIV, HBV, HCV or syphilis. Separate rules for a patient using her own eggs or a partner using his sperm provide limited pathways in specified circumstances, such as documented viral suppression, specialist advice, protective laboratory protocols and informed consent. The existence of those patient-specific pathways does not turn an infection-positive person into an eligible anonymous donor.
Consent, anonymity and genetic protection
Anonymity and non-commercial donation are regulated safeguards, not optional clinic preferences. Annex 1 item 5.7 restricts disclosure of anonymous donors and prohibits selling reproductive cells. Reasonable expense reimbursement is treated differently from a donor's commercial fee; the standard sets conditions on compensation. It also limits egg donors to no more than five donations with at least four months between them, and establishes sperm-donor use controls, including a 20-insemination-cycle threshold with a narrow existing-embryo sibling exception. A clinic should show its register-check method. The 20-cycle restriction in item 5.7.1 is expressly framed for circumstances where the number of pregnancies already resulting from that donor is unknown; it must not be presented as an unconditional limit applying identically to every known donor history.
Genetic assessment has both compulsory exclusion criteria and recommended screening. Articles 7 and 13 require assessment of specified serious personal or family genetic risks; additional carrier tests and counselling are described in the standard. It matters whether the rule says 'must', 'recommended', or requires a personalised medical judgment. A negative commercial genetic panel cannot guarantee the health of a future child or waive mandatory counselling, and an abnormal finding calls for a documented specialist decision rather than automatic generalisation.
Decision guide and documents
Use this decision matrix before paying a deposit: (1) the recipient carries a pregnancy using her own eggs: assess her own-treatment indication, screening and consent; (2) the recipient carries using donated eggs: assess donor selection, notarised consent, tests, provenance and recipient consent; (3) the recipient carries using non-partner sperm: assess donor eligibility, screening, quarantine and release; (4) another woman will carry for intended parents: stop the routine donor-IVF checklist and obtain specialist legal advice on the proposed gestational arrangement first. These are distinct branches, not alternative ways to approve surrogacy.
Collect the treatment indication and proposed protocol, every participant's role and identification, the donor's consents and screening summaries, proof of related-donor status where relevant, microbiology and serology dates, any committee assessment, genetic counselling or PGT-A requirement, and the laboratory's traceability and quarantine record. Request a clear account of where material was collected and whether it was imported. Do not circulate donors' confidential identifying data unnecessarily: the clinic should document compliance and disclose only what applicable law allows.
Ask the medical provider in writing: Which exact provision permits this patient's treatment? Which donor category applies? Which tests are legally required and which additional tests are clinic policy? Who checks donor-register entries and release criteria? How are unexpected results, withdrawal of consent and cancelled cycles handled? If the clinic insists that age 38 is an absolute donor cutoff, or that all infectious findings have identical consequences, request the legal clause and a clinician's explanation of the actual distinction.
A practical example: a potential egg donor aged 39 is not automatically excluded merely by the recommended age of 38; the doctor must assess her suitability, and article 13 specifies PGT-A for embryos resulting from donors aged 38 or above. This does not override other eligibility criteria. Another example: a sperm bank's statement 'fully screened' does not establish whether the 180-day rule or its narrow retesting exception applies to a particular donated sample. Demand batch-specific confirmation without exposing protected donor identity.
Refusals, limits and next steps
When a clinic refuses a procedure, request the reason, the medical finding or cited legal provision, and a copy of records the patient is legally entitled to obtain. A second clinical opinion may address disputed medical suitability; a Bulgarian lawyer should review a contested interpretation of law or the handling of donor information. Do not pressure staff to omit tests, backdate consent or disguise the intended gestational carrier. Administrative complaints or legal remedies depend on the actual refusal and competent authority, not a universal appeal form.
The researched sources do not establish that a cross-border surrogacy contract will be enforceable in Bulgaria, that a future child will acquire a particular parentage or nationality, or that an imported donor-embryo transfer is exempt from local rules. Those are separate questions requiring jurisdiction-specific legal review. This page also does not certify the current licence, pricing, waiting list or internal protocols of any Bulgarian clinic. A provider's offer, even in writing, is no substitute for a legal basis and laboratory proof.
The safe sequence is to define who will provide gametes and carry the pregnancy; confirm the current consolidated Bulgarian legal text and clinic authorisation; obtain a clinician's written assessment of the actual donor and recipient path; verify consent, testing, quarantine and traceability; then obtain independent advice before any payment or transfer involving a third-party carrier. Bottom line: donor treatment and surrogacy must never be treated as interchangeable merely because both may involve IVF.
Official legal and administrative sources
- S01 — Държавен вестник, Наредба № Н-2 от 12 юли 2023 г. за дейности по асистирана репродукция
- S02 — Държавен вестник, Закон за здравето (initial official publication)
- S03 — Ministry of Health: assisted-reproduction facility compliance certificate
- S04 — Bulgarian administrative service 1087, egg-donor register checks
